BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 10450695)

  • 1. Is there a relationship between 99mTc-Sestamibi uptake and oxyphil cell content in hyperparathyroidism?
    Staudenherz A; Leitha T
    J Nucl Med; 1999 Aug; 40(8):1402-3. PubMed ID: 10450695
    [No Abstract]   [Full Text] [Related]  

  • 2. Preoperative localization of parathyroid lesions in hyperparathyroidism: relationship between technetium-99m-MIBI uptake and oxyphil cell content.
    Carpentier A; Jeannotte S; Verreault J; Lefebvre B; Bisson G; Mongeau CJ; Maheux P
    J Nucl Med; 1998 Aug; 39(8):1441-4. PubMed ID: 9708524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technetium Tc 99m sestamibi sensitivity in oxyphil cell-dominant parathyroid adenomas.
    Bleier BS; LiVolsi VA; Chalian AA; Gimotty PA; Botbyl JD; Weber RS
    Arch Otolaryngol Head Neck Surg; 2006 Jul; 132(7):779-82. PubMed ID: 16847189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tc-99m sestamibi uptake mimicking parathyroid adenoma in a patient with primary hyperparathyroidism and occult multiple myeloma.
    Chowdhury FU; Scarsbrook AF
    Clin Nucl Med; 2008 Mar; 33(3):198-200. PubMed ID: 18287846
    [No Abstract]   [Full Text] [Related]  

  • 5. 'Low dose' 99mTc-Sestamibi for radioguided surgery of primary hyperparathyroidism.
    Rubello D; Piotto A; Medi F; Gross MD; Shapiro B; Erba P; Mariani G; Pelizzo MR;
    Eur J Surg Oncol; 2005 Mar; 31(2):191-6. PubMed ID: 15698737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of preoperative localization studies and intraoperative parathyroid hormone assay in patients with primary hyperparathyroidism and double adenoma.
    Haciyanli M; Lal G; Morita E; Duh QY; Kebebew E; Clark OH
    J Am Coll Surg; 2003 Nov; 197(5):739-46. PubMed ID: 14585407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro accumulation of technetium-99m-sestamibi in human parathyroid mitochondria.
    Hetrakul N; Civelek AC; Stagg CA; Udelsman R
    Surgery; 2001 Dec; 130(6):1011-8. PubMed ID: 11742331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic and radiopharmacokinetic factors affecting gamma probe-guided parathyroidectomy.
    Ugur O; Bozkurt MF; Hamaloglu E; Sokmensuer C; Etikan I; Ugur Y; Sayek I; Gulec SA
    Arch Surg; 2004 Nov; 139(11):1175-9. PubMed ID: 15545562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of 99mTc-sestamibi uptake in brown adipose tissue with SPECT-CT.
    Belhocine T; Shastry A; Driedger A; Urbain JL
    Eur J Nucl Med Mol Imaging; 2007 Jan; 34(1):149. PubMed ID: 17021807
    [No Abstract]   [Full Text] [Related]  

  • 10. Intraoperative parathyroid hormone testing: what have we learned?
    Proctor MD; Sofferman RA
    Laryngoscope; 2003 Apr; 113(4):706-14. PubMed ID: 12671433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative parathyroid localization: correlating false-negative technetium 99m sestamibi scans with parathyroid disease.
    Westreich RW; Brandwein M; Mechanick JI; Bergman DA; Urken ML
    Laryngoscope; 2003 Mar; 113(3):567-72. PubMed ID: 12616216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hürthle cell adenoma: false positive in (99m)Tc-sestamibi hyperparathyroidism study].
    Morera Ocón FJ; Sales Maicas MA; García-Granero Ximénez M; Agramunt Lerma M
    Med Clin (Barc); 2009 Jun; 133(3):118-9. PubMed ID: 19539827
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemotherapy and uptake of technetium-99m sestamibi in breast cancer: reply.
    Fukushima K; Ishii K; Sakai E
    Eur J Nucl Med; 1998 Jul; 25(7):816-8. PubMed ID: 9741995
    [No Abstract]   [Full Text] [Related]  

  • 14. Technetium-99m sestamibi uptake in hepatocellular carcinoma.
    Derebek E
    Eur J Nucl Med; 1998 Nov; 25(11):1587-8. PubMed ID: 9882185
    [No Abstract]   [Full Text] [Related]  

  • 15. 99mTc sestamibi uptake by acute pulmonary embolism.
    Wittram C; Jones SE; Scott JA
    AJR Am J Roentgenol; 2006 Dec; 187(6):1611-3. PubMed ID: 17114558
    [No Abstract]   [Full Text] [Related]  

  • 16. Focal breast uptake of 99mTc-sestamibi in a man with spindle cell lipoma.
    Malek H; Ghaedian T; Yaghoobi N; Rastgou F; Bitarafan-Rajabi A; Firoozabadi H
    J Nucl Cardiol; 2012 Jun; 19(3):618-20. PubMed ID: 22415820
    [No Abstract]   [Full Text] [Related]  

  • 17. The relationship between 99Tc(m)-sestamibi uptake and ultrastructural cell types of thyroid tumours.
    Sarikaya A; Huseyinova G; Irfanoğlu ME; Erkmen N; Cermik TF; Berkarda S
    Nucl Med Commun; 2001 Jan; 22(1):39-44. PubMed ID: 11233550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technetium-99m-sestamibi cellular uptake: passive or secondary active transport?
    Maublant J; Baggott J
    J Nucl Med; 1997 Jul; 38(7):1170. PubMed ID: 9225815
    [No Abstract]   [Full Text] [Related]  

  • 19. A peculiar Factor VIII-related antigen staining of an oxyphilic cell nodule within an intrathyroidal parathyroid adenoma.
    Altinok G; Ozdamar SO
    Pathol Int; 1999 Mar; 49(3):266-9. PubMed ID: 10338086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxyphilic parathyroid adenoma and lithium therapy.
    de Celis G; Fiter M; Latorre X; Llebaria C
    Lancet; 1998 Sep; 352(9133):1070. PubMed ID: 9759787
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.